Skip to main content
Seaweed Commons

Biomaterials & Biotechnology

Building biomaterials, running extraction, or developing a biorefinery?

This pathway covers the upstream and material-science end of the seaweed sector: extraction operations, biorefinery development, bioplastics, packaging, and any business where seaweed is the raw feedstock for a technical material output. The tools here focus on facility economics, capital planning, compound yields, and compliance.

Product categories covered — hover for a definition

Bioplastics

Bioplastics

Materials made fully or partly from biological feedstocks (like alginate) that can replace conventional petroleum-based plastics, often with improved biodegradability. Seaweed-derived bioplastics are still largely at the research and pilot stage but are a high-growth area globally.

Biorefinery

Biorefinery

An integrated facility that processes seaweed biomass into multiple co-products including compounds, energy, and materials to maximise value from each batch of raw material. Analogous to a petroleum refinery but built around biological feedstocks.

Extraction

Extraction

The physical or chemical process of isolating specific compounds (alginate, fucoidan, carrageenan) from seaweed biomass for use in downstream products. Extraction method significantly affects compound quality, yield, and environmental footprint.

Packaging

Packaging

Seaweed-derived materials used as sustainable alternatives to plastic packaging including films, wraps, coatings, and formed containers derived from alginate or agar. A growing commercial category driven by single-use plastic regulation.

Technical Materials

Technical Materials

Engineered materials derived from seaweed polysaccharides with defined physical properties. Used in wound care, 3D bioprinting scaffolds, and specialty industrial applications where precise material behaviour is required.

Wound Care

Wound Care

Medical-grade alginate dressings and gels used in clinical wound management. Alginate fibres form a gel on contact with wound exudate, maintaining a moist healing environment. An established commercial category with strong clinical evidence.

3D Bioprinting

3D Bioprinting

Alginate-based bioinks that allow living cells to be printed into three-dimensional tissue structures for regenerative medicine, drug testing, and research applications. Alginate is valued for its biocompatibility and gentle crosslinking chemistry.

Cleantech

Cleantech

Technologies derived from or processing seaweed that reduce environmental impact, including carbon capture cultivation, bioenergy production, bioplastic substitution, and nutrient cycling systems. Increasingly supported by cleantech and climate funds.

Mobile: definitions appear in the compounds section below.

Key compounds & feedstocks

Primary compounds and extraction outputs relevant to biomaterial and biotech applications. Choosing the right compound determines your extraction process, your facility specifications, and which industrial or medical markets your product can enter.

AlginateThe foundational industrial hydrocolloid of the biomaterials sector. Used in bioplastics, films, wound care dressings, 3D bioprinting bioinks, and encapsulation systems. Viscosity grade is the primary quality determinant for industrial applications.
AgarA high-strength gelling agent with a long history in technical applications. Used in microbiological culture media, specialty casting materials, and art applications. Industrial agar grades are distinct from food-grade specifications.
CarrageenanIndustrial-grade carrageenan is used in drilling fluids, textile sizing, paper coatings, and technical gels. Specification requirements for industrial applications differ substantially from food-grade uses.
Bioactive ExtractsBroad extraction streams including polyphenols, pigments, and mixed polysaccharide fractions that serve as feedstocks for downstream biotech applications. Typically requires further fractionation and purification before end use.

Builders in this space

See who is running extraction operations, developing biomaterials, and building biorefinery infrastructure in Canada.

Explore Builders →

Planning a facility or extraction operation?

Biorefinery development involves complex capital planning, permitting, and process design decisions. Our advisors can help you scope your facility, build your business case, and identify the right funding programs.

Talk to an advisor